National Health Investors Quarterly Balance Sheets Chart
Quarterly
|
Annual
National Health Investors Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-03-31 | 2005-12-31 | 2002-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
real estate properties: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
land | 209,444,000 | 201,983,000 | 191,909,000 | 181,173,000 | 181,173,000 | 180,749,000 | 180,749,000 | 180,749,000 | 180,749,000 | 181,949,000 | 177,527,000 | 176,795,000 | 178,787,000 | 180,503,000 | 186,658,000 | 200,559,000 | 212,609,000 | 220,361,000 | 220,361,000 | 220,423,000 | 219,919,000 | 219,575,000 | 213,617,000 | 213,102,000 | 214,661,000 | 207,380,000 | 202,196,000 | 200,197,000 | 200,197,000 | 192,953,000 | 191,623,000 | 188,783,000 | 183,943,000 | 182,923,000 | 172,003,000 | 164,279,000 | 163,476,000 | 140,634,000 | 137,532,000 | 136,336,000 | 130,340,000 | 127,665,000 | 127,566,000 | 94,320,000 | 93,950,000 | 93,290,000 | 91,770,000 | 70,844,000 | 65,674,000 | 58,869,000 | 58,869,000 | 62,693,000 | 50,210,000 | 49,114,000 | 44,620,000 | 44,368,000 | 42,493,000 | 41,035,000 | 31,647,000 | 33,805,000 |
buildings and improvements | 2,880,115,000 | 2,823,073,000 | 2,751,071,000 | 2,627,928,000 | 2,622,633,000 | 2,596,232,000 | 2,593,696,000 | 2,588,823,000 | 2,587,123,000 | 2,604,742,000 | 2,549,019,000 | 2,560,646,000 | 2,599,734,000 | 2,601,905,000 | 2,707,422,000 | 2,818,321,000 | 3,024,923,000 | 3,042,763,000 | 3,041,616,000 | 3,041,613,000 | 3,025,619,000 | 2,990,554,000 | 2,836,673,000 | 2,827,227,000 | 2,823,170,000 | 2,676,127,000 | 2,599,526,000 | 2,599,302,000 | 2,598,660,000 | 2,485,951,000 | 2,471,602,000 | 2,421,302,000 | 2,408,660,000 | 2,396,383,000 | 2,285,122,000 | 2,204,625,000 | 2,156,763,000 | 1,954,537,000 | 1,945,323,000 | 1,939,943,000 | 1,843,519,000 | 1,856,475,000 | 1,854,855,000 | 1,380,623,000 | 1,374,727,000 | 1,363,727,000 | 1,320,567,000 | 854,915,000 | 795,455,000 | 637,043,000 | 636,994,000 | 625,361,000 | 499,681,000 | 487,396,000 | 436,602,000 | 434,309,000 | 421,030,000 | 410,655,000 | 362,907,000 | 367,981,000 |
construction in progress | 8,283,000 | 6,663,000 | 10,568,000 | 11,329,000 | 8,347,000 | 6,389,000 | 5,913,000 | 7,019,000 | 5,925,000 | 3,924,000 | 3,352,000 | 2,835,000 | 1,781,000 | 851,000 | 468,000 | 2,784,000 | 4,167,000 | 3,131,000 | 3,093,000 | 2,528,000 | 1,600,000 | 18,003,000 | 24,556,000 | 19,954,000 | 20,889,000 | 19,810,000 | 16,643,000 | 7,890,000 | 5,093,000 | 4,781,000 | 2,678,000 | 10,835,000 | 20,201,000 | 18,018,000 | 15,729,000 | 24,772,000 | 27,782,000 | 18,702,000 | 13,011,000 | 12,343,000 | 10,219,000 | 8,978,000 | 6,428,000 | 18,197,000 | 13,973,000 | 11,198,000 | 9,665,000 | 19,469,000 | 9,954,000 | 4,922,000 | 2,673,000 | 718,000 | 15,900,000 | 9,864,000 | 3,922,000 | 359,000 | 1,263,000 | |||
total real estate properties | 3,097,842,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: accumulated depreciation | -781,390,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of credit loss reserves of | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17,465 and 20,249, respectively | 252,939,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 18,640,000 | 135,004,000 | 24,289,000 | 15,550,000 | 14,766,000 | 11,357,000 | 22,347,000 | 16,579,000 | 17,411,000 | 13,875,000 | 19,291,000 | 28,811,000 | 43,435,000 | 36,121,000 | 37,412,000 | 48,393,000 | 32,544,000 | 113,375,000 | 43,344,000 | 42,198,000 | 46,853,000 | 46,049,000 | 5,215,000 | 5,882,000 | 5,635,000 | 5,177,000 | 4,659,000 | 2,638,000 | 3,045,000 | 3,230,000 | 3,063,000 | 3,926,000 | 3,470,000 | 5,685,000 | 4,832,000 | 4,197,000 | 3,876,000 | 28,808,000 | 13,286,000 | 14,197,000 | 3,293,000 | 4,190,000 | 3,287,000 | 3,559,000 | 7,157,000 | 6,245,000 | 11,312,000 | 7,450,000 | 36,469,000 | 6,050,000 | 9,172,000 | 4,410,000 | 9,800,000 | 6,927,000 | 15,484,000 | 21,901,000 | 21,097,000 | 4,363,000 | 132,469,000 | 43,062,000 |
straight-line rent receivable | 89,097,000 | 86,334,000 | 85,321,000 | 84,257,000 | 83,549,000 | 82,295,000 | 79,103,000 | 76,895,000 | 81,959,000 | 79,697,000 | 94,739,000 | 96,198,000 | 99,895,000 | 97,723,000 | 98,354,000 | 95,703,000 | 92,418,000 | 89,090,000 | 85,629,000 | 86,044,000 | 82,634,000 | 78,672,000 | 75,123,000 | 105,620,000 | 114,397,000 | 108,771,000 | 102,046,000 | 97,359,000 | 90,224,000 | 83,273,000 | 77,024,000 | 72,518,000 | 66,904,000 | 62,034,000 | 65,062,000 | 59,777,000 | 53,646,000 | 47,462,000 | 41,243,000 | 35,154,000 | 31,383,000 | 27,181,000 | 22,886,000 | 18,691,000 | 16,778,000 | 15,065,000 | 13,652,000 | 12,370,000 | 11,030,000 | 9,782,000 | 9,768,000 | 7,690,000 | 6,783,000 | 5,837,000 | ||||||
other assets | 18,831,000 | 29,543,000 | 22,753,000 | 23,163,000 | 23,982,000 | 26,053,000 | 24,063,000 | 24,691,000 | 26,604,000 | 28,768,000 | 16,585,000 | 17,385,000 | 15,947,000 | 22,181,000 | 21,036,000 | 33,389,000 | 21,664,000 | 22,270,000 | 21,583,000 | 29,416,000 | 39,522,000 | 32,020,000 | 31,659,000 | 31,746,000 | 29,987,000 | 27,298,000 | 24,608,000 | 23,126,000 | 22,160,000 | 18,212,000 | 18,598,000 | 16,380,000 | 15,021,000 | 12,322,000 | ||||||||||||||||||||||||||
total assets1 | 2,695,959,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt | 1,118,835,000 | 1,262,985,000 | 1,146,041,000 | 1,136,302,000 | 1,136,035,000 | 1,139,266,000 | 1,135,051,000 | 1,144,438,000 | 1,134,815,000 | 1,176,014,000 | 1,147,511,000 | 1,114,999,000 | 1,104,495,000 | 1,249,044,000 | 1,242,883,000 | 1,285,287,000 | 1,434,744,000 | 1,524,725,000 | 1,499,285,000 | 1,528,968,000 | 1,554,241,000 | 1,548,904,000 | 1,440,465,000 | 1,449,360,000 | 1,471,787,000 | 1,287,205,000 | 1,281,675,000 | 1,220,135,000 | 1,225,720,000 | 1,160,226,000 | 1,145,497,000 | 1,111,292,000 | 1,145,005,000 | 1,145,691,000 | 1,115,981,000 | 1,086,018,000 | 1,072,835,000 | 937,138,000 | 926,257,000 | 1,009,144,000 | 893,032,000 | 899,420,000 | 862,726,000 | 640,963,000 | 638,019,000 | 629,033,000 | 617,080,000 | 391,362,000 | 386,778,000 | 203,250,000 | 203,250,000 | 194,250,000 | 120,000,000 | 95,300,000 | 48,125,000 | 48,750,000 | 49,375,000 | 17,252,000 | 61,763,000 | |
accounts payable and accrued expenses | 33,046,000 | 29,189,000 | 37,757,000 | 32,508,000 | 33,200,000 | 26,782,000 | 34,304,000 | 29,326,000 | 28,952,000 | 24,626,000 | 25,905,000 | 22,997,000 | 25,336,000 | 19,112,000 | 23,181,000 | 20,886,000 | 25,728,000 | 23,673,000 | 25,189,000 | 32,144,000 | 33,026,000 | 34,701,000 | 26,313,000 | 28,625,000 | 27,104,000 | 22,532,000 | 19,890,000 | 18,750,000 | 16,814,000 | 16,514,000 | 17,476,000 | 19,144,000 | 18,301,000 | 21,599,000 | 20,003,000 | 36,090,000 | 26,235,000 | 24,805,000 | 19,397,000 | 19,887,000 | 14,432,000 | 14,822,000 | 15,718,000 | 12,583,000 | 11,084,000 | 7,058,000 | 8,011,000 | 7,809,000 | 3,894,000 | 3,590,000 | 4,301,000 | 4,114,000 | 3,933,000 | 2,818,000 | 3,915,000 | 3,268,000 | 2,782,000 | 2,688,000 | ||
dividends payable | 42,726,000 | 42,024,000 | 41,119,000 | 39,260,000 | 39,098,000 | 39,082,000 | 39,069,000 | 39,069,000 | 39,069,000 | 39,050,000 | 39,050,000 | 39,050,000 | 40,190,000 | 41,265,000 | 41,266,000 | 41,266,000 | 41,266,000 | 50,550,000 | 49,818,000 | 49,314,000 | 49,226,000 | 49,226,000 | 46,817,000 | 46,154,000 | 45,525,000 | 45,359,000 | 42,700,000 | 42,231,000 | 42,172,000 | 41,532,000 | 39,456,000 | 39,454,000 | 38,935,000 | 38,930,000 | 35,863,000 | 35,863,000 | 35,239,000 | 34,564,000 | 32,637,000 | 31,931,000 | 31,931,000 | 31,931,000 | 28,864,000 | 25,455,000 | 25,452,000 | 25,450,000 | 24,293,000 | 20,489,000 | 20,489,000 | 19,375,000 | 24,793,000 | 18,646,000 | 18,074,000 | 18,061,000 | 17,059,000 | 17,041,000 | 17,041,000 | 15,896,000 | 12,524,000 | 9,339,000 |
deferred income | 4,058,000 | 4,102,000 | 4,277,000 | 4,612,000 | 5,107,000 | 5,429,000 | 6,009,000 | 5,432,000 | 5,284,000 | 4,944,000 | 5,052,000 | 5,094,000 | 4,282,000 | 4,285,000 | 5,725,000 | 6,694,000 | 9,209,000 | 10,972,000 | 12,614,000 | 14,207,000 | 16,371,000 | 17,373,000 | 19,750,000 | 21,590,000 | 22,641,000 | 24,550,000 | 5,954,000 | 5,218,000 | 5,833,000 | 871,000 | 784,000 | 477,000 | 1,013,000 | 3,573,000 | 2,472,000 | 2,643,000 | 2,827,000 | 1,071,000 | 1,372,000 | 1,415,000 | 1,701,000 | 3,901,000 | 1,185,000 | 1,230,000 | 1,294,000 | 1,334,000 | 1,374,000 | 1,643,000 | 1,633,000 | 1,714,000 | 1,480,000 | 1,423,000 | 1,286,000 | 3,142,000 | 4,797,000 | |||||
total liabilities1 | 1,198,665,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable noncontrolling interest | 9,321,000 | 9,540,000 | 9,790,000 | 8,925,000 | 9,169,000 | 9,425,000 | 9,656,000 | 9,922,000 | 10,172,000 | 9,520,000 | 9,825,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
national health investors, inc. stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock | 278,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47,473,160 and 45,687,942 shares issued and outstanding, respectively | 475,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital in excess of par value | 1,863,582,000 | 1,804,679,000 | 1,736,831,000 | 1,601,450,000 | 1,606,199,000 | 1,605,912,000 | 1,603,757,000 | 1,602,892,000 | 1,602,026,000 | 1,601,257,000 | 1,599,427,000 | 1,598,385,000 | 1,597,679,000 | 1,596,258,000 | 1,591,182,000 | 1,590,194,000 | 1,589,205,000 | 1,594,336,000 | 1,540,946,000 | 1,510,804,000 | 1,505,265,000 | 1,505,001,000 | 1,505,948,000 | 1,467,289,000 | 1,419,228,000 | 1,406,822,000 | 1,369,919,000 | 1,336,779,000 | 1,333,874,000 | 1,288,861,000 | 1,289,919,000 | 1,295,709,000 | 1,254,516,000 | 1,254,780,000 | 1,173,588,000 | 1,173,588,000 | 1,135,726,000 | 1,085,896,000 | 1,085,136,000 | 1,035,551,000 | 1,035,318,000 | 1,035,160,000 | 1,033,896,000 | 762,918,000 | 762,703,000 | 762,483,000 | 753,635,000 | 470,892,000 | 470,639,000 | 469,569,000 | 467,843,000 | 467,600,000 | 467,357,000 | 467,110,000 | 465,503,000 | 465,236,000 | 464,963,000 | 461,663,000 | 464,389,000 | 440,360,000 |
retained earnings | 2,675,981,000 | 2,638,994,000 | 2,604,829,000 | 2,561,587,000 | 2,533,047,000 | 2,497,791,000 | 2,466,844,000 | 2,434,799,000 | 2,405,453,000 | 2,365,674,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative dividends | -3,060,393,000 | -3,017,666,000 | -2,975,642,000 | -2,934,523,000 | -2,895,263,000 | -2,856,165,000 | -2,817,083,000 | -2,778,014,000 | -2,738,945,000 | -2,699,876,000 | -956,116,000 | -664,729,000 | -516,632,000 | |||||||||||||||||||||||||||||||||||||||||||||||
total national health investors, inc. stockholders’ equity | 1,479,645,000 | 1,426,474,000 | 1,228,950,000 | 1,244,417,000 | 1,247,972,000 | 1,260,111,000 | 1,268,968,000 | 1,267,489,000 | 1,306,370,000 | 1,392,220,000 | 1,479,293,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interests | 8,328,000 | 8,571,000 | 8,912,000 | 9,533,000 | 9,886,000 | 10,169,000 | 10,439,000 | 10,792,000 | 11,235,000 | 11,587,000 | 9,078,000 | 9,281,000 | 9,504,000 | 10,149,000 | 10,345,000 | 10,530,000 | 10,711,000 | 10,953,000 | 11,110,000 | 11,435,000 | ||||||||||||||||||||||||||||||||||||||||
total equity | 1,487,973,000 | 1,435,045,000 | 1,375,387,000 | 1,238,483,000 | 1,254,303,000 | 1,258,141,000 | 1,264,391,000 | 1,270,903,000 | 1,280,203,000 | 1,279,076,000 | 1,280,081,000 | 1,315,448,000 | 1,401,501,000 | 1,488,797,000 | 1,516,983,000 | 1,549,206,000 | 1,557,060,000 | 1,562,715,000 | 1,522,945,000 | 1,504,002,000 | 1,503,469,000 | 1,506,993,000 | 1,498,252,000 | 1,462,993,000 | 1,419,686,000 | 1,209,590,000 | 1,206,990,000 | 1,178,643,000 | 1,139,689,000 | 1,142,460,000 | 1,044,666,000 | 1,046,507,000 | 1,046,441,000 | 1,049,933,000 | 781,020,000 | 780,382,000 | 783,185,000 | 777,160,000 | 490,413,000 | 468,987,000 | 468,376,000 | 468,047,000 | 450,411,000 | |||||||||||||||||
total liabilities and equity | 2,695,959,000 | 2,782,885,000 | 2,614,371,000 | 2,460,090,000 | 2,476,912,000 | 2,478,125,000 | 2,488,480,000 | 2,499,090,000 | 2,498,495,000 | 2,533,230,000 | 2,507,424,000 | 2,838,876,000 | 3,120,489,000 | 3,042,235,000 | 2,750,570,000 | 2,671,009,000 | 2,673,236,000 | 2,559,428,000 | 2,545,821,000 | 2,519,932,000 | 2,511,042,000 | 2,515,979,000 | 2,403,633,000 | 2,387,770,000 | 2,335,454,000 | 2,159,234,000 | 2,146,349,000 | 2,133,125,000 | 2,012,820,000 | 2,019,716,000 | 1,982,960,000 | 1,488,168,000 | 1,483,127,000 | 1,473,202,000 | 1,455,820,000 | 917,114,000 | 887,234,000 | 700,141,000 | 705,981,000 | 675,273,000 | ||||||||||||||||||||
less accumulated depreciation | -761,462,000 | -742,295,000 | -723,606,000 | -705,829,000 | -690,790,000 | -673,276,000 | -656,155,000 | -638,631,000 | -625,743,000 | -611,688,000 | -599,423,000 | -593,036,000 | -582,175,000 | -576,668,000 | -593,215,000 | -622,943,000 | -618,299,000 | -597,638,000 | -576,605,000 | -555,762,000 | -534,905,000 | -514,453,000 | -494,834,000 | -487,591,000 | -468,562,000 | -451,483,000 | -433,484,000 | -415,332,000 | -397,538,000 | -380,202,000 | -363,035,000 | -345,992,000 | -329,173,000 | -313,080,000 | -297,193,000 | -281,963,000 | -272,783,000 | -259,059,000 | -245,409,000 | -233,202,000 | -225,304,000 | -212,300,000 | -202,605,000 | -193,018,000 | -183,488,000 | -174,262,000 | -177,820,000 | -172,097,000 | -167,549,000 | -163,146,000 | -169,293,000 | -153,459,000 | -150,063,000 | -143,474,000 | -141,375,000 | -138,427,000 | -129,519,000 | -131,784,000 | -98,655,000 | |
real estate properties | 2,270,257,000 | 2,211,253,000 | 2,096,824,000 | 2,106,324,000 | 2,092,580,000 | 2,107,082,000 | 2,120,436,000 | 2,135,166,000 | 2,164,872,000 | 2,118,210,000 | 2,140,853,000 | 2,187,266,000 | 2,201,084,000 | 2,317,880,000 | 2,428,449,000 | 2,618,756,000 | 2,647,956,000 | 2,667,432,000 | 2,687,959,000 | 2,691,376,000 | 2,693,227,000 | 2,560,393,000 | 2,565,449,000 | 2,571,129,000 | 2,434,755,000 | 2,366,882,000 | 2,373,905,000 | 2,388,618,000 | 2,286,147,000 | 2,285,701,000 | 2,257,885,000 | 2,266,812,000 | 2,268,151,000 | 2,159,774,000 | 2,096,483,000 | 2,066,058,000 | 1,841,090,000 | 1,836,807,000 | 1,843,213,000 | 1,750,876,000 | 1,767,814,000 | 1,776,549,000 | 1,290,535,000 | 1,289,632,000 | 1,284,727,000 | 1,247,740,000 | 767,408,000 | 698,986,000 | 533,285,000 | 535,390,000 | 519,479,000 | 412,332,000 | 396,311,000 | 341,670,000 | 337,302,000 | 325,096,000 | 322,171,000 | 263,129,000 | 304,394,000 | |
mortgage and other notes receivable, net of reserve of 18,910 and 20,249, respectively | 259,770,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
straight-line rents receivable | 88,311,000 | 87,150,000 | 84,713,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total assets | 2,782,885,000 | 2,614,371,000 | 2,460,090,000 | 2,476,912,000 | 2,478,125,000 | 2,488,480,000 | 2,499,090,000 | 2,498,495,000 | 2,533,230,000 | 2,507,424,000 | 2,508,785,000 | 2,587,291,000 | 2,802,503,000 | 2,838,876,000 | 2,912,177,000 | 3,077,445,000 | 3,183,273,000 | 3,120,489,000 | 3,139,273,000 | 3,166,971,000 | 3,167,835,000 | 3,042,235,000 | 3,019,360,000 | 2,997,381,000 | 2,806,268,000 | 2,750,570,000 | 2,671,009,000 | 2,673,236,000 | 2,559,428,000 | 2,545,821,000 | 2,519,932,000 | 2,511,042,000 | 2,515,979,000 | 2,403,633,000 | 2,387,770,000 | 2,335,454,000 | 2,159,234,000 | 2,146,349,000 | 2,133,125,000 | 2,012,820,000 | 2,019,716,000 | 1,982,960,000 | 1,488,168,000 | 1,483,127,000 | 1,473,202,000 | 1,455,820,000 | 917,114,000 | 887,234,000 | 700,141,000 | 705,981,000 | 675,273,000 | 598,400,000 | 572,904,000 | 522,297,000 | 521,959,000 | 522,139,000 | 497,880,000 | 587,932,000 | 651,064,000 | |
liabilities and stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities | 1,338,300,000 | 1,229,194,000 | 1,212,682,000 | 1,213,440,000 | 1,210,559,000 | 1,214,433,000 | 1,218,265,000 | 1,208,120,000 | 1,244,634,000 | 1,217,518,000 | 1,182,140,000 | 1,174,303,000 | 1,313,706,000 | 1,321,893,000 | 1,362,971,000 | 1,520,385,000 | 1,620,558,000 | 1,597,544,000 | 1,635,271,000 | 1,663,502,000 | 1,660,842,000 | 1,543,983,000 | 1,556,367,000 | 1,577,695,000 | 1,390,284,000 | 1,360,857,000 | 1,307,609,000 | 1,311,864,000 | 1,239,547,000 | 1,223,704,000 | 1,192,265,000 | 1,224,616,000 | 1,228,695,000 | 1,194,043,000 | 1,180,780,000 | 1,156,811,000 | 1,019,545,000 | 1,003,889,000 | 1,088,459,000 | 966,313,000 | 973,275,000 | 933,027,000 | 707,148,000 | 702,745,000 | 690,017,000 | 678,660,000 | 426,701,000 | 418,247,000 | 231,765,000 | 237,934,000 | 224,862,000 | 153,128,000 | 127,290,000 | 74,813,000 | 74,539,000 | 74,621,000 | 61,055,000 | 162,964,000 | 250,635,000 | |
46,693,671 and 45,687,942 shares issued and outstanding, respectively | 467,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 20,249 and 15,476, respectively | 268,926,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 5,669,000 | 5,669,000 | 5,004,000 | 5,004,000 | 10,875,000 | 13,167,000 | 26,670,000 | 43,302,000 | 32,608,000 | 56,669,000 | 131,988,000 | 66,398,000 | 17,443,000 | 22,581,000 | 18,420,000 | 18,420,000 | 3,745,000 | 3,745,000 | 1,346,000 | 1,346,000 | 1,611,000 | 1,611,000 | 1,611,000 | 29,381,000 | 29,381,000 | 29,381,000 | 29,381,000 | 29,381,000 | 33,420,000 | |||||||||||||||||||||||||||||||
national health investors stockholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45,687,942 and 43,409,841 shares issued and outstanding, respectively | 457,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total national health investors, inc. stockholders' equity | 1,366,475,000 | 1,253,952,000 | 1,270,225,000 | 1,507,083,000 | 1,539,057,000 | 1,546,715,000 | 1,552,185,000 | 1,493,049,000 | 1,492,359,000 | 1,495,558,000 | 1,462,366,000 | 1,419,045,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 19,411 and 15,476, respectively | 232,550,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,622,064 and 43,409,841 shares issued and outstanding, respectively | 436,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 15,921 and 15,476, respectively | 240,850,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,442,849 and 43,409,841 shares issued and outstanding, respectively | 434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 15,475 and 15,476, respectively | 258,874,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,424,841 and 43,409,841 shares issued and outstanding, respectively | 434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 15,476 and 15,338, respectively | 245,271,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
national health investors, inc. stockholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,409,841 and 43,388,742 shares issued and outstanding, respectively | 434,000 | 434,000 | 434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 15,808 and 15,338, respectively | 242,960,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 15,017 and 15,338, respectively | 223,852,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 14,964 and 15,338, respectively | 219,942,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,388,742 shares issued and outstanding | 434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 15,338 and 5,210, respectively | 233,141,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
lease deposit liabilities | 8,838,000 | 8,838,000 | 9,438,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 10,638,000 | 21,275,000 | 21,325,000 | 21,275,000 | 21,275,000 | 22,375,000 | 22,375,000 | 22,475,000 | 21,325,000 | 21,275,000 | 21,275,000 | 21,275,000 | 21,275,000 | 21,275,000 | 21,275,000 | 21,275,000 | 21,648,000 | 22,775,000 | 22,775,000 | 22,775,000 | 22,775,000 | |||||||||||||||||||||||||||
43,388,742 and 45,850,599 shares issued and outstanding, respectively | 434,000 | 434,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative dividends in excess of net income | -329,636,000 | -292,449,000 | -205,906,000 | -117,424,000 | -84,558,000 | -49,768,000 | -39,316,000 | -37,233,000 | -22,015,000 | -9,337,000 | -2,618,000 | -1,898,000 | -3,566,000 | -2,817,000 | 969,000 | 1,126,000 | -439,000 | -22,695,000 | -22,127,000 | -18,495,000 | -34,806,000 | -30,510,000 | -29,363,000 | -23,623,000 | -25,372,000 | -33,447,000 | ||||||||||||||||||||||||||||||||||
noncontrolling interest | 9,856,000 | 9,900,000 | 621,000 | 627,000 | 641,000 | 9,072,000 | 9,117,000 | 9,168,000 | 9,762,000 | 9,824,000 | 9,902,000 | 10,008,000 | 9,897,000 | 10,355,000 | 10,505,000 | 10,614,000 | 10,711,000 | 10,782,000 | 10,869,000 | 10,865,000 | 10,964,000 | |||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 6,940 and 5,210, respectively | 207,169,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable noncontrolling interests | 11,197,000 | 11,487,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity | 2,508,785,000 | 2,587,291,000 | 2,802,503,000 | 2,912,177,000 | 3,077,445,000 | 3,183,273,000 | 3,139,273,000 | 3,166,971,000 | 3,167,835,000 | 3,019,360,000 | 2,997,381,000 | 2,806,268,000 | 587,932,000 | |||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 5,214 and 5,210, respectively | 204,277,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44,655,156 and 45,850,599 shares issued and outstanding, respectively | 447,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 5,134 and 5,210, respectively | 316,390,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45,850,868 and 45,850,599 shares issued and outstanding, respectively | 459,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 5,210 and 4,946, respectively | 299,952,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45,850,599 and 45,185,992 shares issued and outstanding, respectively | 459,000 | 459,000 | 459,000 | 459,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -1,828,000 | -3,633,000 | -5,377,000 | -7,149,000 | -8,865,000 | -10,735,000 | -12,131,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 5,139 and 4,946, respectively | 284,608,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 5,171 and 4,946, respectively | 284,177,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of reserve of 4,856 and 4,946, respectively | 301,318,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of credit loss reserve of 4,946 and — | 292,427,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45,185,992 and 44,587,486 shares issued and outstanding, respectively | 452,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total national health investors stockholders' equity | 1,512,234,000 | 1,497,631,000 | 1,209,590,000 | 1,206,990,000 | 1,169,571,000 | 1,130,572,000 | 1,133,292,000 | 1,034,904,000 | 1,036,683,000 | 1,036,539,000 | 1,039,925,000 | 771,123,000 | 770,027,000 | 772,680,000 | 766,546,000 | 479,702,000 | 458,205,000 | 457,507,000 | 457,182,000 | 439,447,000 | ||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable, net of credit loss reserve of 4,907 and — | 287,282,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44,729,157 and 44,587,486 shares issued and outstanding, respectively | 447,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage and other notes receivable | 300,130,000 | 286,320,000 | 340,143,000 | 315,316,000 | 306,454,000 | 257,481,000 | 246,111,000 | 155,461,000 | 149,676,000 | 145,845,000 | 141,486,000 | 149,299,000 | 141,107,000 | 150,098,000 | 133,493,000 | 183,993,000 | 160,062,000 | 150,720,000 | 135,031,000 | 117,828,000 | 99,681,000 | 101,529,000 | 63,630,000 | 60,728,000 | 60,854,000 | 60,871,000 | 60,639,000 | 59,367,000 | 65,229,000 | 80,059,000 | 84,250,000 | 79,325,000 | 82,199,000 | 118,800,000 | 201,236,000 | |||||||||||||||||||||||||
44,650,002 and 44,587,486 shares issued and outstanding | 447,000 | 447,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity method investment and other assets | 56,610,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative net income in excess (deficit) of dividends | 2,241,000 | -5,331,000 | 19,862,000 | -569,000 | 3,043,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
44,587,486 and 42,700,411 shares issued and outstanding | 446,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -3,432,000 | -4,809,000 | -3,459,000 | 342,000 | 1,299,000 | 2,513,000 | 2,138,000 | 1,335,000 | -822,000 | -2,719,000 | -3,124,000 | -3,079,000 | 5,731,000 | 8,456,000 | 6,074,000 | 26,268,000 | 27,910,000 | 875,000 | 4,555,000 | 3,820,000 | 6,223,000 | 7,109,000 | 6,024,000 | 8,741,000 | 9,538,000 | 8,970,000 | 9,982,000 | 9,786,000 | 7,555,000 | 6,375,000 | 8,147,000 | |||||||||||||||||||||||||||||
43,956,238 and 42,700,411 shares issued and outstanding | 440,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative net income in (excess) deficit of dividends | -554,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,357,018 and 42,700,411 shares issued and outstanding | 434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative net income in excess of dividends | 2,842,000 | 8,388,000 | 18,068,000 | 23,686,000 | 24,938,000 | 29,270,000 | 32,605,000 | 34,262,000 | 34,624,000 | 35,173,000 | 29,873,000 | 24,548,000 | 27,379,000 | 18,024,000 | 765,000 | |||||||||||||||||||||||||||||||||||||||||||||
stockholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43,199,318 and 42,700,411 shares issued and outstanding | 432,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders' equity | 1,415,984,000 | 1,389,713,000 | 1,363,400,000 | 1,361,372,000 | 1,319,881,000 | 1,322,117,000 | 1,327,667,000 | 1,286,426,000 | 1,287,284,000 | 445,272,000 | 445,614,000 | 447,484,000 | 447,420,000 | 447,518,000 | 436,825,000 | 400,429,000 | ||||||||||||||||||||||||||||||||||||||||||||
42,700,411 and 41,532,154 shares issued and outstanding | 427,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42,230,851 and 41,532,154 shares issued and outstanding | 422,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42,171,866 and 41,532,154 shares issued and outstanding | 422,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41,532,154 shares issued and outstanding | 415,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41,532,154 and 39,847,860 shares issued and outstanding, respectively | 415,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41,531,038 and 39,847,860 shares issued and outstanding, respectively | 415,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40,984,289 and 39,847,860 shares issued and outstanding, respectively | 410,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40,978,934 and 39,847,860 shares issued and outstanding, respectively | 410,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
marketable securities | 11,745,000 | 23,871,000 | 23,751,000 | 58,532,000 | 72,744,000 | 35,148,000 | 14,664,000 | 16,387,000 | 15,503,000 | 13,275,000 | 13,991,000 | 13,438,000 | 12,650,000 | 13,577,000 | 14,205,000 | 14,845,000 | 12,884,000 | 11,806,000 | 13,142,000 | 11,772,000 | 9,510,000 | 10,372,000 | 21,378,000 | 21,666,000 | 19,553,000 | 15,763,000 | ||||||||||||||||||||||||||||||||||
equity-method investment and other assets | 21,271,000 | 19,673,000 | 15,022,000 | 27,358,000 | 29,615,000 | 50,245,000 | 50,421,000 | 50,705,000 | 50,556,000 | 46,180,000 | 46,903,000 | 66,656,000 | 14,402,000 | 17,537,000 | ||||||||||||||||||||||||||||||||||||||||||||||
39,847,860 and 38,396,727 shares issued and outstanding, respectively | 398,000 | 398,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
real estate purchase liabilities | 750,000 | 750,000 | 750,000 | 750,000 | 3,750,000 | 3,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | 2,600,000 | 5,856,000 | 5,856,000 | 4,256,000 | 4,256,000 | 6,478,000 | 9,478,000 | 9,478,000 | 4,000,000 | ||||||||||||||||||||||||||||||||||||||||
39,154,872 and 38,396,727 shares issued and outstanding, respectively | 392,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38,403,978 and 38,396,727 shares issued and outstanding, respectively | 384,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in preferred stock, at cost | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | 38,132,000 | |||||||||||||||||||||||||||||||||||||||||
38,396,727 and 37,485,902 shares issued and outstanding, respectively | 384,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37,566,221 and 37,485,902 shares issued and outstanding, respectively | 376,000 | 376,000 | 376,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale, net of depreciation | 8,467,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37,485,902 and 33,051,176 shares issued and outstanding, respectively | 375,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33,058,124 and 33,051,176 shares issued and outstanding, respectively | 331,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33,054,599 and 33,051,176 shares issued and outstanding, respectively | 331,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33,051,999 and 33,051,176 shares issued and outstanding, respectively | 330,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33,051,176 and 27,857,217 shares issued and outstanding, respectively | 330,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27,876,176 and 27,857,217 shares issued and outstanding, respectively | 279,000 | 279,000 | 279,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in unconsolidated entity and other assets | 12,507,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred costs and other assets | 12,172,000 | 11,091,000 | 2,366,000 | 1,387,000 | 629,000 | 1,249,000 | 2,692,000 | 418,000 | 10,268,000 | 5,254,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
27,857,217 and 27,751,208 shares issued and outstanding, respectively | 279,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27,830,311 and 27,751,208 shares issued and outstanding, respectively | 278,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | 1,266,000 | 1,373,000 | 473,000 | 323,000 | 1,243,000 | 3,701,000 | 5,581,000 | 6,857,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27,806,129 and 27,751,208 shares issued and outstanding, respectively | 278,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders' equity | 598,400,000 | 572,904,000 | 522,297,000 | 521,959,000 | 522,139,000 | 497,880,000 | 651,064,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
mortgage notes receivable | 77,853,000 | 79,328,000 | 76,516,000 | 77,283,000 | 74,009,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
27,751,208 shares issued and outstanding, respectively | 278,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gains on marketable securities | 7,589,000 | 5,327,000 | 7,279,000 | 15,725,000 | 14,448,000 | 11,822,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
real estate purchase liability | 4,000,000 | 4,000,000 | 4,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnest money deposit | 3,250,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27,689,392 shares issued and outstanding, respectively | 277,000 | 277,000 | 277,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
borrowings under revolving credit facility | 33,935,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27,629,505 shares issued and outstanding, respectively | 276,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative net income | 916,554,000 | 613,208,000 | 458,613,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in preferred stock | 38,132,000 | 38,132,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unsecured public notes | 100,000,000 | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
convertible subordinated debentures | 201,000 | 41,633,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable and other accrued expenses | 26,471,000 | 28,511,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued interest | 3,374,000 | 4,592,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 424,968,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in real estate mortgage investment conduits | 36,366,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and guarantees | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cumulative convertible preferred stock, .01 par value; | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10,000,000 shares authorized; | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
747,994 shares issued and outstanding; stated at liquidation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preference of 25 per share | 18,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26,682,994 and 26,004,318 shares, respectively, issued and | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
outstanding | 266,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unrealized losses on marketable securities | -878,000 |
We provide you with 20 years of balance sheets for National Health Investors stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of National Health Investors. Explore the full financial landscape of National Health Investors stock with our expertly curated balance sheets.
The information provided in this report about National Health Investors stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.